These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 28571043)

  • 21. Collagen triple helix repeat containing-1 negatively regulated by microRNA-30c promotes cell proliferation and metastasis and indicates poor prognosis in breast cancer.
    Lai YH; Chen J; Wang XP; Wu YQ; Peng HT; Lin XH; Wang WJ
    J Exp Clin Cancer Res; 2017 Jul; 36(1):92. PubMed ID: 28697793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4.
    Dong Y; Liu Y; Jiang A; Li R; Yin M; Wang Y
    Mol Cell Biochem; 2018 Feb; 439(1-2):95-104. PubMed ID: 28795314
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor-microRNA-212/132 axis in human breast cancer suppresses metastasis by targeting SOX4.
    Hanieh H
    Mol Cancer; 2015 Sep; 14():172. PubMed ID: 26377202
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-941 regulates the proliferation of breast cancer cells by altering histone H3 Ser 10 phosphorylation.
    Surapaneni SK; Bhat ZR; Tikoo K
    Sci Rep; 2020 Oct; 10(1):17954. PubMed ID: 33087811
    [TBL] [Abstract][Full Text] [Related]  

  • 25. MicroRNA-4317 predicts the prognosis of breast cancer and inhibits tumor cell proliferation, migration, and invasion.
    Sheng Y; Hu R; Zhang Y; Luo W
    Clin Exp Med; 2020 Aug; 20(3):417-425. PubMed ID: 32279128
    [TBL] [Abstract][Full Text] [Related]  

  • 26. MicroRNA-421 inhibits breast cancer metastasis by targeting metastasis associated 1.
    Pan Y; Jiao G; Wang C; Yang J; Yang W
    Biomed Pharmacother; 2016 Oct; 83():1398-1406. PubMed ID: 27583980
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-485-5p inhibits the progression of breast cancer cells by negatively regulating MUC1.
    Wang X; Zhou X; Zeng F; Wu X; Li H
    Breast Cancer; 2020 Jul; 27(4):765-775. PubMed ID: 32144736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of miR-660-5p expression suppresses tumor development and metastasis in human breast cancer.
    Shen Y; Ye YF; Ruan LW; Bao L; Wu MW; Zhou Y
    Genet Mol Res; 2017 Feb; 16(1):. PubMed ID: 28252173
    [TBL] [Abstract][Full Text] [Related]  

  • 29. MicroRNA-100 suppresses the migration and invasion of breast cancer cells by targeting FZD-8 and inhibiting Wnt/β-catenin signaling pathway.
    Jiang Q; He M; Guan S; Ma M; Wu H; Yu Z; Jiang L; Wang Y; Zong X; Jin F; Wei M
    Tumour Biol; 2016 Apr; 37(4):5001-11. PubMed ID: 26537584
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evaluation of exosomal miR-9 and miR-155 targeting PTEN and DUSP14 in highly metastatic breast cancer and their effect on low metastatic cells.
    Kia V; Paryan M; Mortazavi Y; Biglari A; Mohammadi-Yeganeh S
    J Cell Biochem; 2019 Apr; 120(4):5666-5676. PubMed ID: 30335891
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-494 suppresses the progression of breast cancer in vitro by targeting CXCR4 through the Wnt/β-catenin signaling pathway.
    Song L; Liu D; Wang B; He J; Zhang S; Dai Z; Ma X; Wang X
    Oncol Rep; 2015 Jul; 34(1):525-31. PubMed ID: 25955111
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MicroR-760 suppresses cancer stem cell subpopulation and breast cancer cell proliferation and metastasis: By down-regulating NANOG.
    Han ML; Wang F; Gu YT; Pei XH; Ge X; Guo GC; Li L; Duan X; Zhu MZ; Wang YM
    Biomed Pharmacother; 2016 May; 80():304-310. PubMed ID: 27133070
    [TBL] [Abstract][Full Text] [Related]  

  • 33. MicroRNA-145 inhibits growth and migration of breast cancer cells through targeting oncoprotein ROCK1.
    Zheng M; Sun X; Li Y; Zuo W
    Tumour Biol; 2016 Jun; 37(6):8189-96. PubMed ID: 26715279
    [TBL] [Abstract][Full Text] [Related]  

  • 34. NT21MP negatively regulates paclitaxel-resistant cells by targeting miR‑155‑3p and miR‑155-5p via the CXCR4 pathway in breast cancer.
    Wang Y; Yan L; Zhang L; Xu H; Chen T; Li Y; Wang H; Chen S; Wang W; Chen C; Yang Q
    Int J Oncol; 2018 Sep; 53(3):1043-1054. PubMed ID: 30015868
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MicroRNA-383-5p acts as a potential prognostic biomarker and an inhibitor of tumor cell proliferation, migration, and invasion in breast cancer.
    Zhang J; Kong X; Shi Q; Zhao B
    Cancer Biomark; 2020; 27(4):423-432. PubMed ID: 31903982
    [TBL] [Abstract][Full Text] [Related]  

  • 36. MicroRNA-409-5p is upregulated in breast cancer and its downregulation inhibits cancer development through downstream target of RSU1.
    Yu H; Xing H; Han W; Wang Y; Qi T; Song C; Xu Z; Li H; Huang Y
    Tumour Biol; 2017 May; 39(5):1010428317701647. PubMed ID: 28459205
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-296 functions as a tumor suppressor in breast cancer by targeting FGFR1 and regulating the Wnt/β-catenin signaling pathway.
    Sun WM; Tao W; Li JC; Zhu DM; Miao Y
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(23):10422-10432. PubMed ID: 31841196
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MiR-146a suppresses the expression of CXCR4 and alters survival, proliferation and migration rate in colorectal cancer cells.
    Afshar-Khamseh R; Javeri A; Taha MF
    Tissue Cell; 2021 Dec; 73():101654. PubMed ID: 34601384
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glutamate metabotropic receptor 4 (GRM4) inhibits cell proliferation, migration and invasion in breast cancer and is regulated by miR-328-3p and miR-370-3p.
    Xiao B; Chen D; Zhou Q; Hang J; Zhang W; Kuang Z; Sun Z; Li L
    BMC Cancer; 2019 Sep; 19(1):891. PubMed ID: 31492116
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR-448 inhibits the epithelial-mesenchymal transition in breast cancer cells by directly targeting the E-cadherin repressor ZEB1/2.
    Ma P; Ni K; Ke J; Zhang W; Feng Y; Mao Q
    Exp Biol Med (Maywood); 2018 Mar; 243(5):473-480. PubMed ID: 29368542
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.